Published in World J Surg Oncol on January 31, 2011
Ectopic Cushing's syndrome due to a mesenteric neuroendocrine tumour. Ann R Coll Surg Engl (2012) 0.75
Ex-vivo Resection and Small-Bowel Auto-transplantation for the Treatment of Tumors at the Root of the Mesentery. Int J Organ Transplant Med (2014) 0.75
The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci (2004) 4.13
Carcinoid tumors of the gastrointestinal tract. Ann Surg (1974) 1.55
Surgical management for carcinoid tumors of small bowel, appendix, colon, and rectum. World J Surg (1996) 1.51
Current management of gastrointestinal carcinoid tumors. J Gastrointest Surg (2004) 1.49
Management of midgut carcinoids. J Surg Oncol (2005) 1.28
Surgery on neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab (2007) 1.21
The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors. Surgery (2008) 1.16
Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids. Surgery (1981) 1.15
Surgical treatment of advanced-stage carcinoid tumors: lessons learned. Ann Surg (2005) 1.11
Carcinoid tumors and fibrosis: an association with no explanation. Am J Gastroenterol (2004) 1.05
Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowel. QJM (2010) 1.00
Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World J Surg (2000) 0.98
Midgut carcinoid tumours: surgical treatment and prognosis. Best Pract Res Clin Gastroenterol (2005) 0.95
Computed tomography of abdominal carcinoid tumour. Br J Radiol (1986) 0.95
Partial abdominal evisceration, ex vivo resection, and intestinal autotransplantation for the treatment of pathologic lesions of the root of the mesentery. J Am Coll Surg (2003) 0.92
Stenting of the superior mesenteric vein in midgut carcinoid disease with large mesenteric masses. World J Surg (2010) 0.91
Partial abdominal exenteration, ex vivo resection of a large mesenteric fibroma, and successful orthotopic intestinal autotransplantation. Surgery (2000) 0.91
Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors. World J Surg (1996) 0.88
In situ surgical procedures for locally advanced pancreatic cancer: partial abdominal evisceration and intestinal autotransplantation. J Hepatobiliary Pancreat Surg (2009) 0.85
Lymphatic mapping helps to define resection margins for midgut carcinoids. Surgery (2009) 0.83
Intestinal autotransplantation for adenocarcinoma of pancreas involving the mesenteric root: our experience and literature review. Pancreas (2007) 0.82
Computed tomography of abdominal carcinoid tumors. AJR Am J Roentgenol (1984) 0.81
Abdominal surgery in patients with midgut carcinoid tumors. Acta Oncol (1991) 0.80
Islet cell carcinoma treated by induction regional chemotherapy and radical total pancreatectomy with liver revascularization and small bowel autotransplantation. Surgery (1996) 0.77
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med (2004) 9.80
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med (2010) 7.11
Strategies to improve long-term outcomes after renal transplantation. N Engl J Med (2002) 6.76
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J Clin Oncol (2009) 4.54
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol (2005) 3.83
Hepatic portal venous gas: the ABCs of management. Arch Surg (2009) 3.76
Right-liver living donor transplantation for decompensated end-stage liver disease. Liver Transpl (2002) 2.86
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg (2015) 2.79
Case records of the Massachusetts General Hospital. Case 23-2005. A 57-year-old man with a mass in the liver. N Engl J Med (2005) 2.67
Case records of the Massachusetts General Hospital. Case 15-2009. A 25-year-old man with coma after cardiac arrest. N Engl J Med (2009) 2.65
CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant (2004) 2.45
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma. J Clin Oncol (2006) 2.38
Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer. J Clin Oncol (2007) 2.33
Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Ann Surg (2013) 2.26
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. Lancet Oncol (2009) 2.23
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer. J Clin Oncol (2008) 2.04
High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. J Virol (2007) 2.01
Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol (2006) 2.00
Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates. Sci Transl Med (2011) 1.97
Neuroendocrine tumors. J Natl Compr Canc Netw (2012) 1.91
Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol (2002) 1.84
Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Transplantation (2004) 1.82
FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Oncologist (2013) 1.76
Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation (2002) 1.75
Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int (2002) 1.72
Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol (2005) 1.71
Phase 1/2 study of everolimus in advanced hepatocellular carcinoma. Cancer (2011) 1.59
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma. Cancer (2007) 1.56
Liver transplantation for malignancy. Oncologist (2005) 1.54
Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw (2015) 1.51
Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance. Liver Transpl (2008) 1.50
Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. Int J Radiat Oncol Biol Phys (2010) 1.50
A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation. Transplantation (2003) 1.41
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma. Clin Cancer Res (2014) 1.33
Promotion of altruistic donation. Transplantation (2009) 1.33
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2013) 1.29
Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation (2010) 1.25
Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation (2004) 1.22
Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer. Cancer (2011) 1.20
A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation (2003) 1.19
Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation. Transpl Int (2005) 1.17
Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study. Clin Cancer Res (2013) 1.16
Immuno-intervention for the induction of transplantation tolerance through mixed chimerism. Semin Immunol (2011) 1.12
Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation (2011) 1.12
A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors. Cancer Chemother Pharmacol (2010) 1.11
Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation (2002) 1.10
Preclinical and clinical studies on the induction of renal allograft tolerance through transient mixed chimerism. Curr Opin Organ Transplant (2011) 1.10
Added value of selected images embedded into radiology reports to referring clinicians. J Am Coll Radiol (2010) 1.05
Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation (2002) 1.05
Caring for one of our own. Oncologist (2014) 1.04
Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant (2003) 1.03
Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl (2004) 1.02
Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head. Int J Radiat Oncol Biol Phys (2010) 1.00
Panitumumab in patients with KRAS wild-type colorectal cancer after progression on cetuximab. Oncologist (2011) 0.98
Mutational analysis and clinical correlation of metastatic colorectal cancer. Cancer (2014) 0.98
Excorporeal normothermic machine perfusion resuscitates pig DCD livers with extended warm ischemia. J Surg Res (2011) 0.97
Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older. Int J Radiat Oncol Biol Phys (2011) 0.96
Differential effects of denileukin diftitox IL-2 immunotoxin on NK and regulatory T cells in nonhuman primates. J Immunol (2012) 0.95
Suppressive regulatory T cell activity is potentiated by glycogen synthase kinase 3{beta} inhibition. J Biol Chem (2010) 0.94
The need for tolerance in pediatric organ transplantation. Pediatrics (2008) 0.92
Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma. Cardiovasc Intervent Radiol (2013) 0.92
Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates. Transplantation (2006) 0.91
Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? Arch Surg (2004) 0.91
Living donor liver transplantation: how can we better protect the donors? Transplantation (2007) 0.91
Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transpl Int (2006) 0.91
Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys (2012) 0.90
Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma. Invest New Drugs (2009) 0.89
Biliary reconstruction following right adult living donor liver transplantation end-to-end or end-to-side duct-to-duct anastomosis. Langenbecks Arch Surg (2002) 0.88
A Bridge to Somewhere: 25-day Survival After Pig-to-Baboon Liver Xenotransplantation. Ann Surg (2016) 0.87
Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons. Xenotransplantation (2012) 0.87
Liver transplantation--a vision realized. N Engl J Med (2012) 0.86
Biliary reconstruction and complications after living-donor liver transplantation. HPB (Oxford) (2009) 0.85
Psychiatric care of patients undergoing organ transplantation. Transplantation (2009) 0.85
Mixed chimerism to induce tolerance: lessons learned from nonhuman primates. Transplant Rev (Orlando) (2009) 0.85
Transarterial chemoembolization with Doxorubicin-eluting microspheres for inoperable hepatocellular carcinoma. Gastrointest Cancer Res (2011) 0.84
Split-liver transplantation: future use of scarce donor organs. World J Surg (2001) 0.84
Clinical trials for induction of renal allograft tolerance. Curr Opin Organ Transplant (2015) 0.84
Human immune reactivity against liver sinusoidal endothelial cells from GalTα(1,3)GalT-deficient pigs. Cell Transplant (2010) 0.83
Antithymocyte globulin induction in living donor renal transplant recipients: final report of the TAILOR registry. Transplantation (2012) 0.83
Cutaneous Aspergillus ustus in a lung transplant recipient: emergence of a new opportunistic fungal pathogen. J Heart Lung Transplant (2008) 0.83
Induction of allograft tolerance in nonhuman primates and humans. Front Biosci (2007) 0.83
Combined liver and kidney transplantation in a patient with sickle cell disease. Transplantation (2002) 0.83
Long-term experience with liver transplantation for hepatocellular carcinoma. J Gastroenterol (2010) 0.83
Multicenter phase II study of tivozanib (AV-951) and everolimus (RAD001) for patients with refractory, metastatic colorectal cancer. Oncologist (2013) 0.83
Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates. J Immunol (2011) 0.83
Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer. J Gastrointest Cancer (2014) 0.83
Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapy. Gastrointest Cancer Res (2011) 0.82